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Research
Polychlorinated biphenyls (PCBs) are persis-
tent environmental toxicants associated with 
numerous adverse health effects. The wide-
spread commercial use of PCBs, which peaked 
in the 1970s, contributed to the pervasive bio-
accumulation of these toxicants in the environ-
ment (Longnecker et al. 1997). Environmental 
exposure to PCBs is ongoing as a result of con-
tinued use and disposal of products containing 
these toxicants (Prince et al. 2006), widespread 
bioaccumulation of PCBs in the biosphere, and 
bioconcentration in the food chain (Norstrom 
et al. 2009). Meat and fish remain the primary 
source of PCB exposure for most of the adult 
human population and account for consis-
tent PCB accumulation within human tissues 
(Schneider et al. 2007).
Several studies have evaluated associations 
of PCBs with human health effects and have 
demon  strated adverse reproductive (Leoni 
et al. 1989), developmental (Jorissen 2007), 
immunologic (Glynn et al. 2008), and neu-
rologic (Prince et al. 2006) effects. The influ-
ence of PCBs on cancer risk is well established 
in animal studies (Glauert al. 2008; Lehmann 
et al. 2007); however, human epidemiology 
studies are less consistent. Several epidemio-
logic studies derived from retrospective mor-
tality analysis have linked occupational PCB 
exposure with an increased risk of developing 
malignant melanoma and brain cancer (Hopf 
et al. 2009; Knerr and Schrenk 2006; Loomis 
et al. 1997; Prince et al. 2006; Robinson et al. 
1999; Sinks et al. 1992). Interestingly, the risk 
of developing brain cancer has been shown to 
be independent of cumulative PCB exposure 
(Loomis et al. 1997; Sinks et al. 1992). 
The ability of PCBs to accumulate in 
brain tissue (Caudle et al. 2006; Saghir et al. 
2000; Sipka et al. 2008) is likely related to 
their neuro  toxicity. However, less is known 
about the effects of PCBs on brain endothe-
lium. Previous research from our laboratory 
has demon  strated that PCBs can modulate 
properties of brain endothelial cells in vitro 
and enhance adhesion and transendothelial 
migration of tumor cells (Choi et al. 2003; 
Eum et al. 2004, 2006). However, the inter-
actions of PCBs with brain endothelium and 
the blood–brain barrier (BBB) in vivo are 
virtually unknown. 
The BBB is anatomically situated at the 
level of the cerebral microvascular capillary 
endothelium and it regulates the blood–brain 
exchange. The tight junctions (TJs) limit pas-
sive para  cellular movement of solutes, ions, 
and water across the BBB. They form the 
most apical element of the junctional complex 
and are composed of an intricate complex of 
trans  membrane, accessory, and cyto  plasmic 
proteins that connect the TJs to actin cyto-
skeleton and intra  cellular signaling systems 
(Abbott et al. 2006). The transmembrane 
proteins occludin and claudin-5 form the pri-
mary seal of the TJs. They bind to the intra-
cellular proteins zonula occludens (ZO)-1, 
ZO-2, cingulin, and/or 7H6 that couple the 
TJs to the actin cytoskeleton of endothelial 
cells (Abbott et al. 2006). TJ proteins are also 
important in maintaining barrier polarity and 
are involved in cellular signaling. Disruption 
of the integrity of this system has been asso-
ciated with several central nervous system 
pathologies (Weiss et al. 2009). 
In the present study, we hypothesize that 
individual PCB congeners can influence the 
BBB integrity at the level of the TJs and con-
tribute to the development of brain cancer 
metastasis. We demonstrate that exposure to 
coplanar PCB126, mono-ortho-substituted 
PCB118, and non-coplanar PCB153 can 
differentially alter expression of TJ proteins 
in vivo, induce permeability of brain micro-
vessels, and stimulate formation of brain 
metastases of melanoma cells. Among the stud-
ied compounds, these changes appeared to be 
most advanced in animals exposed to PCB118.
Materials and Methods
Materials.  We  purchased  PCB153 
(2,2´,4,4´,5,5´-hexa  chloro  biphenyl), PCB126 
(3,3´,4,4´,5-penta  chloro  biphenyl), and 
PCB118 (2,3´,4,4´,5-penta  chloro  biphenyl), all 
> 99% pure, from AccuStandard (New Haven, 
CT). Primary anti  bodies for occludin, ZO-1, 
and claudin-5 were obtained from Invitrogen 
(Camarillo, CA), and all secondary antibodies 
were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA). All other chemicals, unless 
otherwise stated, were purchased from Sigma 
(St. Louis, MO).
Animals and PCB exposure. All animal 
procedures were approved by the University of 
Kentucky Animal Care and Use Committee in 
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Ba c k g r o u n d: Polychlorinated biphenyls (PCBs) comprise a ubiquitous class of toxic substances 
associated with carcinogenic and tumor-promoting effects as well as neurotoxic properties in the brain. 
However, the effects of PCBs on the development of tumor metastases are not fully understood.
oB j e c t i v e: We evaluated the hypothesis that exposure to individual PCB congeners can facilitate 
the development of brain metastases in immunocompetent mice via the disruption of the integrity 
of the blood–brain barrier (BBB). 
Me t h o d s : C57/Bl6 mice were exposed to individual PCBs by oral gavage, and 48 hr later they 
were injected with luciferase-labeled K1735 M2 melanoma cells into the internal carotid artery. 
The development of metastatic nodules was monitored by bioluminescent imaging. In addition, we 
evaluated the functional permeability of the BBB by measuring permeability of sodium fluorescein 
across the brain micro  vessels. Expression and colocalization of tight junction (TJ) proteins were 
studied by Western blotting and immunofluorescence microscopy. 
re s u l t s: Oral administration of coplanar PCB126, mono-ortho-substituted PCB118, and non-
coplanar PCB153 (each at 150 µmol/kg body weight) differentially altered expression of the TJ 
proteins claudin-5, occludin, and zonula occludens-1 in brain capillaries. These alterations were 
associated with increased permeability of the BBB. Most importantly, exposure to individual PCB 
congeners enhanced the rate of formation and progression of brain metastases of luciferase-tagged 
melanoma cells. 
co n c l u s i o n s: Our results show for the first time that exposure to individual PCBs can facili-
tate the formation of bloodborne metastases via alterations of the integrity of the brain capillary 
endothelium. 
key w o r d s : blood–brain barrier, brain metastasis, polychlorinated biphenyls, tight junctions. 
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accordance with National Institutes of Health 
(NIH) guidelines (Institute for Laboratory 
Animal Resources 1996). The animals were 
treated humanely and with regard for alle-
viation of suffering. Studies were performed 
on male C57Bl/6 mice (Charles River 
Laboratories, Wilmington, MA), 14–16 weeks 
of age. Mice were gently restrained and admin-
istered via oral gavage with individual PCBs 
(75 or 150 µmol/kg body weight) dissolved 
in vitamin E–stripped safflower oil (Dyetts, 
Bethlehem, PA). PCBs are highly lipophilic 
compounds that are soluble in organic sol-
vents. We chose safflower oil, a natural dietary 
component, as the PCB vehicle. Several bio-
logical effects of PCBs are mediated by oxida-
tive stress; therefore, we used safflower oil that 
was stripped of vitamin E to avoid a possible 
influence of this anti  oxidant. Control animals 
were treated with safflower oil vehicle alone. 
Most of the experiments were performed 48 hr 
after PCB adminis  tration to mimic acute 
exposure characteristic of accidental poison-
ing with PCBs, such as the Yusho incident 
caused by ingestion of rice oil contaminated 
with PCBs (Shimizu et al. 2007). However, 
we analyzed brain metastasis formation for up 
to 9 days after PCB treatment. 
K1735 melanoma cell treatment and 
bioluminescent imaging. K1735 M2 murine 
melanoma cells transfected with a luciferase 
tag were a kind gift from I.J. Fidler (M.D. 
Anderson Cancer Center, Houston, TX). 
Cells were cultured in DMEM glutaMax 
medium (Invitrogen) supplemented with 10% 
fetal bovine serum. Mice were injected with 
5 × 105 cells in 100 µL phosphate-buffered 
saline (PBS) into the internal carotid artery as 
described previously by Chen et al. (2009). 
We monitored the develop  ment of metastatic 
nodules on days 4 and 7 after tumor cell injec-
tion using an IVIS Xenogen bioluminescence 
imager (Caliper LifeSciences, Hopkinton, 
MA). Animals were anesthetized by intraperi-
toneal (IP) injection with sodium pentobar-
bital (50 mg/kg) and treated with d-luciferin 
potassium salt (2 mg/100 µL, IP) to induce 
bioluminescence within proliferating K1735 
cells. Identical instrument settings were used 
for all measurements to allow for adequate data 
comparisons. The experimental model is spe-
cific for the development of brain metasta-
ses. Nevertheless, approximately 2 weeks after 
tumor cell injection (i.e., past the time frame of 
the present study), we observed metastasis for-
mation in peripheral organs, such as the lungs 
and liver, in selected animals (data not shown). 
Microvessel isolation. Brain microvessels 
were isolated as described previously (Seelbach 
et al. 2007). Under anesthesia, animals were 
perfused with saline; the brains were removed 
and immediately immersed in ice-cold iso-
lation buffer A [103 mM sodium chloride 
(NaCl), 4.7 mM potassium chloride (KCl), 
2.5 mM calcium chloride (CaCl2), 1.2 mM 
potassium phosphate (KH2PO4),1.2 mM 
magnesium sulfate (MgSO4), and 15 mM 
HEPES; pH 7.4 with Complete Protease 
Inhibitor (Roche, Indianapolis, IN)]. We 
removed the choroid plexus, meninges, cere-
bellum, and brain stem, and homogenized the 
brains in 5 mL isolation buffer B [103 mM 
NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM 
KH2PO4, 1.2 mM MgSO4, 15 mM HEPES, 
25 mM NaHCO3, 10 mM glucose, 1 mM 
Na pyruvate, and dextran (molecular weight 
64kD;10 g/L); pH 7.4] with Complete 
Protease Inhibitor. We then added 7 µL 
26% dextran to the homogenates and centri-
fuged samples at 5,800 × g for 20 min. The 
supernatants were discarded, and the pellets 
were resuspended in 10 µL isolation buffer 
B and filtered through a 70-µm mesh filter 
(Becton Dickinson, Franklin, NJ). Filtered 
homogenates were repelleted by centrifuga-
tion and either smeared on slides for confocal 
analysis or resuspended in 150 µL of 6 M urea 
lysis buffer with Complete Protease Inhibitor 
for Western blot analyses. Diameters of iso-
lated micro  vessels ranged from 4 to 10 µm. 
Western blotting and immunofluorescence 
microscopy. We performed Western blot-
ting and immuno  fluorescence as described 
previously (Seelbach et al. 2007). We used 
anti-occludin antibody at a dilution of 
1:1,000, anti-claudin-5 antibody at 1:500, 
anti-ZO-1 antibody at 1:500, and anti-actin 
antibody at 1:5,000. The proteins of inter-
est were detected using the ECL Plus detec-
tion system (Amersham, Piscataway, NJ). 
Semiquantitation of protein was performed 
using NIH ImageJ software (Rasband 2009). 
Freshly isolated intact microvessels were 
spread onto glass microscope slides and heat-
fixed for 10 min at 95°C. All primary anti-
bodies were diluted 1:500 in 1% bovine serum 
albumin in PBS. Slides were mounted with 
ProLong Gold Antifade reagent (Invitrogen) 
containing 4´,6-diamidino-2-phenylindole 
(DAPI) to visualize the nuclei. Images were 
acquired using an Olympus BX61WI laser 
scanning confocal microscope (Olympus, 
Melville, NY). 
BBB functional permeability assay. We 
assessed BBB permeability 48 hr after PCB 
administration using an adaptation of a previ-
ously described method (Chen et al. 2009). 
Briefly, animals were injected IP with 200 µL 
10% sodium fluorescein that was allowed 
to circulate for 15 min, and blood was col-
lected via cardiac puncture. Animals were 
then trans  cardially perfused with 0.9% saline 
and brains were harvested. Fluorescence was 
determined using excitation at 485 nm and 
emission at 530 nm. The permeability results 
are presented as a ratio of brain to plasma 
fluorescence intensity. 
Statistical analysis. We compared the treat-
ment and vehicle control groups using one-way 
or two-way analysis of variance and performed 
the pair  wise comparison using Student-
Newman-Keuls post hoc test. Statistical prob-
ability of p < 0.05 was considered significant. 
Results
TJ protein expression level in brain micro  vessels 
after oral administration of individual PCB 
congeners. In the first series of experiments, 
we investigated the influence of individual 
PCB congeners on the expression levels of key 
TJ proteins in brain capillaries. Because PCB 
exposure does not alter mRNA levels of genes 
encoding for TJ proteins (Eum et al. 2008), 
our studies focused on the effects of PCBs on 
Figure 1. Treatment with individual PCB congeners differentially alters the expression of TJ proteins in 
cerebral microvessels of mice 48 hr after treatment with individual PCB congeners (150 µmol/kg) or vehicle. 
(A) Representative Western blots showing expression levels of claudin-5, occludin, and ZO-1. (B) Quantified 
results (mean ± SE ) of TJ protein expression obtained by densitometry analysis of Western blots and nor-
malized to actin levels (n = 3–6 per group). 
*p < 0.05 compared with vehicle. 
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protein expression of claudin-5, occludin, and 
ZO-1. These TJ proteins regulate the integrity 
and the barrier function of the BBB. 
Forty-eight hours after adminis  tration of 
PCB118 or PCB153, we observed a signifi-
cant decrease in the expression of claudin-5 
compared with the vehicle control group. 
Figure 1A illustrates the representative images 
of Western blotting from these experiments; 
the quantified densitometry results are shown 
in Figure 1B. The changes in claudin-5 lev-
els in PCB126-treated animals were not 
significant, despite demon  strating a strong 
trend toward a decrease. The expression level 
of ZO-1 was increased after treatment with 
PCB118 or PCB153, without any changes in 
PCB126-exposed animals. No alterations in 
the expression of occludin were detected after 
any PCB treatment. 
PCB-induced alterations of TJ immun-
ofluorescence and immunolocalization. The 
integrity of the BBB is influenced not only 
by the expression level of TJ proteins but 
also by their cellular locations. Therefore, we 
examined the effects of PCB treatment on 
the localization profiles of claudin-5, occlu-
din, and ZO-1 in freshly isolated micro  vessels 
(Figures 2 and 3). A semiqualitative analysis 
by immuno  fluorescence microscopy indi-
cated that treatment with PCBs decreased the 
intensity and disrupted the continuity of clau-
din-5 immunoreactivity, similar to results of 
Western blotting. These alterations were vis-
ible in all PCB treatment groups we examined 
(Figure 2, arrows). 
Compared with occludin, the immuno-
staining results for ZO-1 suggest a qualitative 
increase in immuno  reactivity after treatment 
with individual PCB congeners (Figure 3). 
Because occludin interacts with ZO-1 at its 
C-terminus, we next determined the effects of 
individual PCB congeners on colocaliza  tion 
Figure 2. PCB exposure decreases claudin-5 immunoreactivity in cerebral microvessels in mice 48 hr after treatment with individual PCB congeners (150 µmol/kg) 
or vehicle. Images were acquired using a 60× oil-immersion lens and confocal microscopy. Claudin-5 immunoreactivity is stained in red; staining with DAPI was 
performed to visualize the nuclei (stained in blue); phase contrast micrographs illustrate the isolated microvessels; and merged micrographs show localized 
claudin-5 immunoreactivity within the microvessels. Arrows illustrate areas of disrupted claudin-5 immuno  reactivity; n = 3–4 per group. 
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Figure 3. Individual PCB congeners differentially influence the staining intensity and association of occludin and ZO-1 in cerebral microvessels in mice 48 hr 
after treatment with PCB118, PCB126, or PCB153 (150 µmol/kg) compared with vehicle controls. Occludin (red) and ZO-1 (green) immuno  reactivity was evaluated 
using confocal microscopy, and images were acquired using a 60× oil-immersion lens. Merged micrographs were obtained by superimposing images of the cor-
responding optical sections stained for occludin and ZO-1, and phase contrast micrographs show localized TJ immunoreactivity within the brain microvessels. 
Regions of occludin and ZO-1 colocalization are depicted in yellow (see arrows); n = 6 per group. 
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staining patterns for these proteins. Confocal 
microscopy suggests that PCB treatment can 
enhance the association between ZO-1 and 
occludin, as shown in yellow in the merged 
and phase-contrast micrographs in Figure 3 
(arrows). The enhanced inter  action between 
ZO-1 and occludin appeared to be most pro-
nounced in cerebral micro  vessels of PCB126-
treated animals, followed by the PCB153 
treatment group. 
Oral administration of PCBs disrupts BBB 
integrity. Alterations of TJ molecular proper-
ties have been associated with alterations of 
BBB integrity (Abbott et al. 2006). Therefore, 
we evaluated the effects of individual PCB 
congeners on permeability of brain micro-
vessels using a low-molecular tracer, sodium 
fluorescein. Forty-eight hours after PCB treat-
ment (150 µmol/kg), we observed a statisti-
cally significant increase in sodium fluorescein 
permeability across the capillary endothe-
lium in all treatment groups (Figure 4). The 
most pronounced permeability changes were 
observed in the PCB118 treatment group. 
Administration of PCBs enhances the for-
mation of brain metastases. We next inves-
tigated the influence of individual PCB 
congeners on the growth rate and progression 
of brain metastases. Mice were administered 
individual PCB congeners by oral gavage, fol-
lowed by injection with melanoma cells into 
the internal carotid artery 48 hr later. We meas-
ured metastatic tumor growth 4 and 7 days 
after tumor cell injection, that is, at the time 
points when initial metastatic nodules have 
been established (day 4) and fully developed 
(day 7). As illustrated in Figure 5A, the growth 
of metastatic tumors in the control group was 
minimal at day 4 after tumor cell injection. 
However, at day 7 the control mice developed 
substantial bio  luminescence corresponding 
to metastatic tumors. Compared with con-
trols, PCB-treated mice displayed a marked 
increase in brain metastasis (Figure 5A,B). 
Brain tumor bioluminescence images demon-
strated a robust tumor growth response for all 
PCB-treated animals. These changes were the 
most evident 7 days after tumor cell injection. 
Animals exposed to PCB118 and PCB126 
displayed relatively greater susceptibility to 
tumor growth compared with PCB153 (Figure 
5A,B). Likewise, survival rate after tumor cell 
Figure 4. Exposure to PCBs increases BBB per-
meability. Mice were treated with individual PCB 
congeners (150 µmol/kg) or vehicle for 48 hr. Then, 
200 µL of 10% sodium fluorescein was injected IP 
and allowed to circulate for 15 min. The ratio of 
brain to plasma sodium fluorescence level serves 
as a marker of brain permeability; results are 
mean ± SE (n = 5–6 per group). 
*p < 0.05 compared with vehicle. 
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Figure 5. The rate and progression of brain metastasis are 
enhanced in mice exposed to individual PCB congeners. Mice 
were treated with PCBs (150 µmol/kg) or vehicle for 48 hr and 
then injected with K1735-luciferase–tagged melanoma cells 
(5 × 105 cells in 100 µL) to the internal carotid artery. Growth of 
brain metastases was measured based on the intensity of the 
bioluminescent signal. (A) Representative images of brains of 
the animals at days 4 and 7 post  injection of K1735 cells normal-
ized to the same color scale. (B) Quantified results of brain tumor 
bioluminescence indicating the progression of brain metastasis 
growth. (C) Animal survival rates for up to 7 days post  injection of 
K1735 cells. For B and C, results are mean ± SE; n = 3–6 per group. 
*p < 0.05 compared with the vehicle-treated group at the same day after 
treatment. #p < 0.05 compared with the corresponding treatment at day 4. PCBs promote brain metastasis formation
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administration was lowest for PCB126- and 
PCB118-treated animals (Figure 5C). 
We also evaluated the dose-dependent 
effects of PCBs on the development of brain 
metastases. Because of the stimulatory effects 
of PCB118 and PCB126 on the develop  ment 
of brain metastases, we included these PCBs 
at 75 and 150 µmol/kg in our experiments. 
The measure  ments of metastatic growth were 
performed at day 4 after injection of tumor 
cells. Compared with controls, PCB118 and 
PCB126 (75 µmol/kg) did not influence the 
magnitude of brain metastasis initiation or 
progression (Figure 6). Consistent with the 
results in Figure 5, only a higher dose of PCBs 
(150 µmol/kg) markedly stimulated brain 
metastasis formation as determined by tumor 
bioluminescence values. 
Discussion
A link between PCB exposure and pathology 
has been strongly established in the literature 
(Hennig et al. 2005; Safe 1989). Both early 
childhood development and adult neurologic 
functions may be impaired by PCB exposure 
(Faroon et al. 2001; Grandjean et al. 2001; 
Petersen et al. 2008). For example, a cohort 
analysis study performed on 7-year-old chil-
dren showed that, in conjunction with mer-
cury exposure, high umbilical cord PCB levels 
augmented neuro  behavioral deficits later in life 
(Grandjean et al. 2001). Further, epidemio-
logic studies support an association between 
PCB exposure and central nervous system dis-
ease, including Parkinson disease, amyotrophic 
lateral sclerosis, non–Alzheimer-related demen-
tia, and brain cancer in adults (Caudle et al. 
2006; Hopf et al. 2009; Steenland et al. 2006). 
The BBB breakdown is a commonality in all 
of these central nervous system disease states 
(Weiss et al. 2009); however, the pathophysi-
ologic influence of PCBs on the BBB function 
is not fully understood. 
Research from our laboratory indicated 
that selected PCB congeners can stimulate 
pro  inflammatory properties (Eum et al. 
2004, 2006). These studies linked PCB expo-
sure with pro  metastatic changes of cultured 
endothelial cells. Indeed, we demonstrated 
that exposure of endothelial cells to ortho-
substituted PCBs can stimulate production of 
inflammatory mediators leading to adhesion 
and transmigration of THP-1 or breast can-
cer cells (MDA-MB-231) (Choi et al. 2003; 
Eum et al. 2004). It appears that activation 
of JAK3, EGFR, Src kinase, and MAP kinase 
signaling cascades may underlie these effects 
(Eum et al. 2004, 2006). However, trans-
endothelial migration of tumor cells may be 
further potentiated by disruption of endothe-
lial cell junctions and hyper  permeability 
across the endothelial barrier. Therefore, in 
the present study we explored the influence 
of both coplanar and noncoplanar PCBs 
on molecular and functional properties of 
the BBB. We focused on three typical PCB 
congeners that maintain different structural 
properties, namely, PCB153, PCB126, and 
PCB118. Noncoplanar PCB153 accounts for 
the majority of PCBs found in environmen-
tal and in biological samples (Faroon et al. 
2001). PCB126 belongs to the coplanar diox-
in-like group of PCBs that act through an aryl 
hydrocarbon receptor (AhR) mechanism. In 
contrast, mono-ortho-substituted PCB118 is a 
weak AhR agonist (Hestermann et al. 2000).
In the present study, the molecular analy  sis 
of TJ proteins indicated that PCBs can differ-
entially modulate TJ expression and/or local-
ization. Exposure to PCB118 and PCB153 
modulated expressional levels of claudin-5 
and ZO-1, whereas PCB126 appeared to pri-
marily influence the coassociation of occludin 
and ZO-1. These findings suggest that PCB 
congeners may be acting through different 
mechanisms to elicit the same functional effect 
(i.e., disrupted barrier integrity and increased 
permeability across the endothelial clefts). 
The precise mechanisms responsible for these 
events have yet to be elucidated; however, they 
are likely to involve redox-responsive reac-
tions. Indeed, PCBs are potent generators 
of reactive oxygen species (Choi et al. 2003; 
Hassoun et al. 2002; Hennig et al. 2002), and 
the alterations of redox signaling contribute to 
the disruption of the BBB function (Haorah 
et al. 2007; Persidsky et al. 2006). The brain 
is highly sensitive to oxidative stress because of 
its high oxygen consumption, high iron and 
lipid content, and low activity for anti  oxidant 
defenses. Studies performed in our laboratory 
(András et al. 2005; Zhong et al. 2008) and 
others (Haorah et al. 2007; Persidsky et al. 
2006) demonstrate that oxidative stress can 
alter the integrity of the BBB at the level of 
the TJs acting through Ras and Rho redox-
responsive elements. The Ras GTPase path-
way plays an important role in the regulation 
of claudin-5, ZO-1, and ZO-2 (Zhong et al. 
2008), and the Rho pathway is critical for 
TJ assembly (Persidsky et al. 2006). Other 
redox-regulated candidate pathways that may 
be involved in PCB-induced alterations of 
TJ protein expression include MAP kinase 
(Krizbai et al. 2005) and PI3K (Schreibelt 
et al. 2007). Finally, these mechanisms may 
involve proteolysis of TJ proteins by matrix 
metalloproteinases (MMPs) and ubiquitina-
tion-proteasome systems (Eum et al. 2008). 
One of the major goals of the present 
study was to develop a model to evaluate the 
effects of PCBs on the development of tumor 
metastases. We focused on brain metastases 
of melanoma cells, because metastatic brain 
tumors originating from malignant mela-
noma are seen frequently in clinical medi  cine 
(Fidler et al. 1999; Gonzalez-Martinez et al. 
2002). Over the last 30 years, the mortality 
rate of malignant melanomas has increased by 
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Figure 6. PCBs enhance rate and progression of brain metastasis in a 
dose-dependent manner. Mice were treated with PCB118 or PCB126 (75 or 
150 µmol/kg) or vehicle by oral gavage. After 48 hr, mice were injected with 
K1735-luciferase–tagged melanoma cells, and the progression of brain metas-
tases was assessed at day 4 after tumor cell injection. (A) Representative 
images of brains normalized to the same color scale. (B) Quantified results of 
brain tumor bioluminescence; results are mean ± SE; n = 4–6 per group. 
*p < 0.05 compared with the vehicle-treated group. #p < 0.05 compared with the 
75-µmol/kg treatment group. Seelbach et al.
484  v o l u m e  118 | n u m b e r 4 | April 2010  •  Environmental Health Perspectives
50% (Geller et al. 2002). Using a modifica-
tion of previously published methods (Chen 
et al. 2009; Fidler et al. 1999; Zhang et al. 
2008), we introduced the highly metastatic 
melanoma cells into the internal carotid artery 
of fully immuno  competent mice. Because 
the internal carotid artery supplies the brain 
parenchyma with blood, tumor cell injection 
into brain vasculature mimics the metastatic 
process in humans in which circulating tumor 
cells adhere and invade capillary endothelium 
(Zhang et al. 2008). Our newly developed 
model resulted in the consistent development 
of metastatic nodules within brain paren-
chyma, an effect that was highly potentiated 
by pre-exposure to individual PCB congeners, 
especially PCB118. Several factors participate 
in the propensity of malignant melanoma to 
selectively target brain tissue (Palmieri et al. 
2007; Rolland et al. 2009); however, tumor 
cell extravasation into the brain is dependent 
upon its inter  actions at the cerebral capillary 
endothelium. Thus, the leaky BBB due to 
PCB-induced alterations of TJ expression in 
brain micro  vessels may facilitate transcapillary 
transfer of tumor cells and contribute to the 
development of brain metastasis. 
Conclusion
The present study indicates that exposure to 
PCBs leads to disruption of the BBB integ-
rity via modulation of TJ protein expression. 
Most important, we demonstrate for the first 
time that oral exposure to specific PCB conge-
ners can enhance the rate of brain metastasis 
growth. These results suggest that alteration 
of BBB integrity is the under  lying mechanism 
of PCB-induced brain metastases and may 
also be involved in neurotoxic and neuro-
developmental effects of these environmental 
toxicants.
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